Who
Robert K. Zeldin
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, MeiraGTx Holdings; Chief Medical Officer, Immunovant; EVP & Chief Medical Officer, Acceleron Pharma.
In numbers
- Trades disclosed
- 58
- Buys
- 1
- Sells
- 0
- Bought
- $40K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 2 Jul 2018
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —7,500 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $22K2,952 at $7.45 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —7,500 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $22K2,952 at $7.45 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —35,000 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $104K13,951 at $7.42 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —35,000 at $0.00 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —35,000 at $0.00 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —35,000 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $104K13,951 at $7.42 | filing |
| 7 Jan 2026filed 28 Apr 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $60K7,814 at $7.73 | filing |
| 7 Jan 2026filed 28 Apr 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $60K7,814 at $7.73 | filing |
| 7 Jan 2026filed 8 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —17,500 | filing |
| 7 Jan 2026filed 8 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $52K6,729 at $7.73 | filing |
| 7 Jan 2026filed 8 Jan 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —17,500 at $0.00 | filing |
| 7 Jan 2026filed 8 Jan 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —17,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.